; and (B) includes— (i) sequencing of the entire genome, of the exome, of a panel of genes, or other regions of the genome; and (ii) any analysis, interpretation, and data report derived from such sequencing. . 3. National Academy of Medicine study (a) In general Not later than 4 years after the date of the enactment of this Act, the Secretary of Health and Human Services shall enter into an arrangement with the National Academy of Medicine under which the Academy agrees to study— (1) how genetic and genomic testing may improve preventative care and precision medicine; (2) how genetic and genomic testing may reduce health disparities; (3) how the Federal Government may help to reduce barriers to genetic and genomic testing, including— (A) encouraging the expansion of health insurance coverage of genetic and genomic testing, including diagnostic, predictive, and presymptomatic testing, and DNA sequencing clinical services (as defined in section 1947 of the Social Security Act (as added by section 2)); (B) supporting the collection of evidence for the clinical utility and appropriate use of genetic and genomic tests; and (C) improving access to genetic counselors, pathologists, and other relevant professions, including strengthening related workforce education and training efforts; (4) (A) the extent to which coverage provisions in the Medicare and Medicaid programs under titles XVIII and XIX of the Social Security Act ( 42 U.S.C. 1395 et seq., 1396 et seq.) may restrain the use of genetic and genomic testing that may improve clinical outcomes for beneficiaries; (B) the extent to which coverage provided pursuant to section 1947 of the Social Security Act (as added by section 2) increased the use of genetic and genomic testing and improved clinical outcomes for beneficiaries; and (C) how the Centers for Medicare & Medicaid Services may make coverage determinations that better suit a precision medicine approach to treatment